Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04461288 · ClinicalTrials.gov registry record · NA

Engaging Sexual and Gender Minority Cigarette Smokers Into Social Media-based Treatment

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
121
Enrollment target

NCT04461288 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 121 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04461288, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target

Study Summary

This research study will evaluate the preliminary efficacy of Pride Posts Plus, a social media-based smoking cessation treatment. A pilot randomized trial (N=120) will compare Pride Posts Plus, which includes a gamification element, to Pride Posts (without gamification) and to a usual care treatment. Participants will be adults who smoke, identify as sexual or gender minorities, and use Facebook. The primary outcome will be biochemically verified 7-day abstinence from smoking at 3 and 6 months. Secondary outcomes will be treatment engagement, a quit attempt (y/n), and thoughts about tobacco abstinence at 3 and 6 mos.

Interventions

  • BEHAVIORAL Social media-based education, counseling, and support
  • OTHER Nicotine replacement therapies (NRT)
  • OTHER Gamification

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2020-05-01
Est. Completion 2022-05-30
Phase NA

What the Registry Record Tells You About NCT04461288

The ClinicalTrials.gov registry entry for NCT04461288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Social media-based education, counseling, and support is the first listed.

NCT04461288 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04461288 about?

NCT04461288 is a clinical study titled "Engaging Sexual and Gender Minority Cigarette Smokers Into Social Media-based Treatment". This research study will evaluate the preliminary efficacy of Pride Posts Plus, a social media-based smoking cessation treatment. A pilot randomized trial (N=120) will compare Pride Posts Plus, which includes a gamification element, to Pride Posts (without gamification) and to a usual care treatment...

What is the current status of trial NCT04461288?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2020-05-01. Estimated completion is 2022-05-30.

What interventions are being tested in trial NCT04461288?

The interventions under investigation include: Social media-based education, counseling, and support (BEHAVIORAL), Nicotine replacement therapies (NRT) (OTHER), Gamification (OTHER).

Who is sponsoring clinical trial NCT04461288?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.